RioDerm-004 by Rion for Fistula: Likelihood of Approval

RioDerm-004 is under clinical development by Rion and currently in Phase I for Fistula.

Feb 20, 2024 - 18:00

RioDerm-004 is under clinical development by Rion and currently in Phase I for Fistula.

Read the original article

Tags:

Previous Article

Not Disclosed Neurodegeneration by Eli Lilly and Co for Neurodegenerative Diseas...

RioDerm-001 by Rion for Diabetic Foot Ulcers: Likelihood of Approval

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Alumis secures $259m to develop therapies for immune dysfunction

Alumis secures $259m to develop therapies for immune dy...

Mar 7, 2024

Enzalutamide by Pfizer for Peritoneal Cancer: Likelihoo...

Dec 24, 2023

Medicines Patent Pool broadens access to generic injectable PrEP for HIV

Medicines Patent Pool broadens access to generic inject...

Mar 31, 2023